Medical Equipment

Hematocrit Test Devices Market 2025–2029: Strategic Opportunities and Growth Insights

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hematocrit test devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Hematocrit Test Devices Market Now And By 2029?

The market for hematocrit test devices has experienced robust expansion recently. Its valuation is projected to increase from $4.63 billion in 2024 to $4.91 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 6.0%. This historical growth was driven by several factors, including enhanced public knowledge of anemia, deficiencies in iron and vitamins, a higher prevalence of chronic diseases, a significant increase in government funding, and overall population expansion.

The hematocrit test devices market size is anticipated to undergo significant expansion in the coming years. This market is projected to escalate to $6.19 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 6.0%. The growth expected during the forecast period can be attributed to the increasing prevalence of anemia, a rise in blood disorder cases, an expanding geriatric population, a growing emphasis on health and fitness, and a broadening need for cardiovascular diagnostic equipment. Dominant trends in the forecast period encompass the introduction of advanced solutions, technological progress in medical science, the development of new efficient and innovative products, technical improvements in hematocrit testing, and overall advancements within the healthcare sector.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15582&type=smp

Which Long-Term Drivers Are Expected To Sustain The Hematocrit Test Devices Market?

The rising incidence of blood disorders is anticipated to fuel the expansion of the hematocrit test devices market in the coming period. A blood disorder is defined as a condition that impacts the various components of human blood, including red blood cells, white blood cells, platelets, and blood plasma. These disorders are becoming more prevalent due to a combination of factors such as genetic predispositions, environmental pollution, and shifts in lifestyle. Hematocrit test devices serve a primary function in measuring the volume percentage of red blood cells within whole blood, thereby offering crucial insights into a patient’s hematological health. Illustratively, in January 2024, a report from the American Cancer Society, a non-profit organization based in the US, estimated approximately 62,770 new cases of leukemia (all types) in the United States for 2024, which are expected to lead to about 23,670 deaths. Among these, roughly 20,800 new instances of acute myeloid leukemia (AML) are foreseen, predominantly affecting adults, with roughly 11,220 deaths attributed to AML, almost exclusively among adult patients. Thus, the increasing number of blood disorder cases is significantly contributing to the growth of the hematocrit test devices market.

How Is The Hematocrit Test Devices Market Classified By Different Segments?

The hematocrit test devicesmarket covered in this report is segmented –

1) By Product: Hematocrit Test Meter, Hematocrit Test Analyzer, Reagents And Consumables

2) By Application: Anemia, Polycythemia Vera, Congenital Heart Diseases, Other Applications

3) By End-User: Hospitals And Ambulatory Surgical Centers, Clinics, Diagnostic And Pathology Labs, Other End-Users

Subsegments:

1) By Hematocrit Test Meter: Handheld Hematocrit Meters, Portable Hematocrit Meters, Desktop Hematocrit Meters, Point-Of-Care Hematocrit Meters, Digital Hematocrit Meters, Battery-Powered Hematocrit Meters

2) By Hematocrit Test Analyzer: Automated Hematocrit Analyzers, Benchtop Hematocrit Analyzers, Semi-Automated Hematocrit Analyzers, Microhematocrit Analyzers, High-Throughput Hematocrit Analyzers, Compact Hematocrit Analyzers

3) By Reagents And Consumables: Hematocrit Test Strips, Hematocrit Pipettes And Capillaries, Blood Sample Collection Tubes For Hematocrit Testing, Quality Control Reagents For Hematocrit Testing, Calibration Standards For Hematocrit Devices, Disposable Test Kits And Consumables

What Current And Upcoming Trends Are Shaping The Hematocrit Test Devices Market?

Leading companies in the hematocrit test device market are developing innovative products, such as complete blood count (CBC) hematology analyzers, to deliver quantitative and qualitative information regarding these blood cells. A complete blood count (CBC) hematology analyzer functions as an automated instrument for measuring and analyzing various blood components, including red blood cells (RBCs), white blood cells (WBCs), and platelets. For instance, in March 2022, Mindray Medical International Limited, a China-based medical device company, introduced the BC-700 hematology analyzer series. This complete blood count (CBC) hematology analyzer incorporates both complete blood count (CBC) and erythrocyte sedimentation rate (ESR) tests. The BC-700 hematology analyzer, along with its counterparts BC-720, BC-760, and BC-780, constitutes a series specifically designed to equip medium-volume laboratories with cutting-edge diagnostic technologies comparable to those available in premium products. The BC-700 Series is a more compact version of the high-end BC-6000 Series, built upon the same platform and distinguished by Mindray’s SF Cube 3D analysis technology. The SF Cube technology employs fluorescence and bi-angular laser scatter signals to analyze target cells in three dimensions.

Who Are The Primary Market Leaders In The Hematocrit Test Devices Market?

Major companies operating in the hematocrit test devices market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton, Dickinson and Company (BD), Terumo Corporation, Beckman Coulter Inc., Mindray Medical International Limited, bioMérieux SA, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Erba Mannheim, Heska Corporation, EKF Diagnostics Holding Plc., Nova Biomedical Corporation, Boule Diagnostics AB, Stanbio Laboratory Lp, Drucker Diagnostics, A. Menarini Diagnostics Srl, Sensa Core, Mikroscan Technologies Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hematocrit-test-devices-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Hematocrit Test Devices Market?

North America was the largest region in the hematocrit test devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematocrit test devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=15582&type=smp

Browse Through More Reports Similar to the Global Hematocrit Test Devices Market 2025, By The Business Research Company

Hematopoietic Stem Cell Transplantation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematopoietic-stem-cell-transplantation-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

Hematology Analyzers And Reagents Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hematology-analyzers-and-reagents-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795